Cargando…
Serum carbonic anhydrase I and II autoantibodies in patients with chronic lymphocytic leukaemia
Cancer is the second most important cause of mortality, and millions of people either have or have had the disease. Leukaemia is one of the most common forms of cancer. Autoantibodies that have developed against the organism’s self-antigens are detected in the sera of subjects with cancer. In recent...
Autores principales: | Mentese, Ahmet, Erkut, Nergiz, Demir, Selim, Yaman, Serap Ozer, Sumer, Aysegul, Erdem, Mehmet, Alver, Ahmet, Sonmez, Mehmet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Polish Society of Experimental and Clinical Immunology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305617/ https://www.ncbi.nlm.nih.gov/pubmed/30588172 http://dx.doi.org/10.5114/ceji.2018.80046 |
Ejemplares similares
-
Autoantibodies Against Carbonic Anhydrase I and II in Patients with Acute Myeloid Leukemia
por: Menteşe, Ahmet, et al.
Publicado: (2017) -
Detection of autoantibodies against carbonic anhydrase I and II in the plasma of patients with gastric cancer
por: Mentese, Ahmet, et al.
Publicado: (2017) -
Anti-Carbonic Anhydrase II Antibodies in End-Stage Renal Disease Patients
por: Alver, Ahmet, et al.
Publicado: (2014) -
The Prognostic Significance of Soluble Urokinase Plasminogen Activator Receptor in Acute Myeloid Leukemia
por: Erkut, Nergiz, et al.
Publicado: (2016) -
The Relationship between Serum Carbonic Anhydrase I-II Autoantibody Levels and Diabetic Retinopathy in Type 1 Diabetes Patients
por: Türk, Adem, et al.
Publicado: (2017)